|
HUMA
|
Humacyte, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
GTHX
|
G1 Therapeutics, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
GLUE
|
Monte Rosa Therapeutics, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
GBIO
|
Generation Bio Co.
|
0.03%
|
US
|
NASDAQ
|
|
FMTX
|
Forma Therapeutics Holdings, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
EYPT
|
EyePoint Pharmaceuticals, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
ESPR
|
Esperion Therapeutics, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
EIGR
|
Eiger BioPharmaceuticals, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
CMPS
|
COMPASS Pathways Plc
|
0.03%
|
US
|
NASDAQ
|
|
ALXO
|
ALX Oncology Holdings Inc.
|
0.03%
|
US
|
NASDAQ
|
|
AKRO
|
Akero Therapeutics, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
AFMD
|
Affimed Therapeutics B.V.
|
0.03%
|
US
|
NASDAQ
|
|
AERI
|
Aerie Pharmaceuticals, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
ADMA
|
ADMA Biologics Inc
|
0.03%
|
US
|
NASDAQ
|
|
ABCM
|
Abcam plc
|
0.03%
|
US
|
NASDAQ
|
|
QSI
|
Quantum-Si
|
0.03%
|
US
|
NASDAQ
|
|
XERS
|
Xeris Pharmaceuticals, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
VSTM
|
Verastem, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
TNYA
|
Tenaya Therapeutics, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
STRO
|
Sutro Biopharma, Inc.
|
0.02%
|
US
|
NASDAQ
|